At week 36, the eating behavior data showed even stronger results than at week 24 for higher doses
PlexusDx supports precision wellness by helping patients understand their peptide pathway predispositions alongside clinical guidance, enabling more targeted conversations with providers about treatment fit and formulation options
Regeneron has executed a partial conversion to Eylea HD (8 mg aflibercept, versus 2 mg in the original), approved in 2023 with a dosing interval advantage that allows less frequent injections for many patients
Label the vial with the reconstitution date the moment you mix it
Both tirzepatide and semaglutide are incretin mimetics with similar benefits, side effects, and research prospects
25, 26 For women who are already noticing a loss of muscle during menopause, this can be especially concerning